Atopic dermatitis and cardiovascular disease: What are the clinical implications? - 04/05/19
Doi : 10.1016/j.jaci.2019.01.008
Aaron M. Drucker, MD a, ⁎ 
, Paula J. Harvey, PhD b
, Paula J. Harvey, PhD b a Division of Dermatology, Department of Medicine, University of Toronto and Women's College Hospital, and the Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada
b Division of Cardiology, Department of Medicine, University of Toronto and Women's College Hospital, and the Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada
∗Corresponding author: Aaron M. Drucker, MD, Rm 6343, Women's College Hospital, 76 Grenville St, Toronto, Ontario M5S1B2, Canada.Rm 6343Women's College Hospital76 Grenville StTorontoOntarioM5S1B2Canada
Key words : Atopic dermatitis, cardiovascular disease
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: In the last 3 years, A. M. Drucker has served as an investigator; has received research funding from Sanofi and Regeneron; has been a consultant for Sanofi, RTI Health Solutions, the Eczema Society of Canada, and the Canadian Agency for Drugs and Technology in Health; and has received honoraria from Prime, Spire Learning, CME Outfitters, and the Eczema Society of Canada, and his institution has received educational grants from Sanofi. P. J. Harvey declares that she has no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 5
P. 1736-1738 - mai 2019 Retour au numéro
Article précédent
- One step forward, 2 steps back: The enigma of preschool wheeze
- Anne M. Fitzpatrick, Leonard B. Bacharier
- Innate lymphoid cells in asthmatic patients
- Corinne Cayrol, Jean-Philippe Girard
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?